Drug
Melanotan II
Melanotan II: highest development phase Phase 2, developed by Hudson Biotech. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Hudson Biotech
Trials
| Drug | Phase | Indication |
|---|---|---|
| Melanotan II (MT-II) NCT07437560 | Phase 2 | NonSegmental Vitiligo |
Latest
No recent events.
Follow Melanotan II on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.